Page last updated: 2024-09-05

atropine and Colorectal Cancer

atropine has been researched along with Colorectal Cancer in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19901 (12.50)18.7374
1990's2 (25.00)18.2507
2000's2 (25.00)29.6817
2010's0 (0.00)24.3611
2020's3 (37.50)2.80

Authors

AuthorsStudies
Darband, SG; Ghaderi-Pakdel, F; Majidinia, M; Mihanfar, A; Sadighparvar, S1
Apostolopoulos, V; Davidson, M; Filippone, RT; Fraser, S; Karakkat, J; Kuol, N; Luwor, R; Nurgali, K; Veale, M1
Apostolopoulos, V; Fraser, S; Godlewski, J; Kmiec, Z; Kuol, N; Nurgali, K; Vogrin, S1
Aliustaoglu, M; Aydin, SZ; Dane, F; Ekenel, M; Gumus, M; Karamanoglu, A; Sengoz, M; Turhal, SN; Yumuk, PF1
Henja, MH; Kornek, GV; Raderer, M; Scheithauer, W; Valencak, J1
Dumot, JA; Easley, KA; Nicol, S; van Stolk, RU; Vargo, JJ; Verzola, E1
Adjei, AA; Alberts, SA; Burch, PA; Elfring, G; Erlichman, C; Goldberg, RM; Miller, LL; Pitot, HC; Reid, JM; Rubin, J; Schaaf, LJ; Skaff, PA; Sloan, JA1
Appelgren, L; Carlstedt, A; Fasth, S; Hultén, L; Nordgren, S1

Trials

3 trial(s) available for atropine and Colorectal Cancer

ArticleYear
The absence of early diarrhea with atropine premedication during irinotecan therapy in metastatic colorectal patients.
    International journal of colorectal disease, 2004, Volume: 19, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Atropine; Camptothecin; Colorectal Neoplasms; Diarrhea; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Injections, Subcutaneous; Irinotecan; Male; Middle Aged; Muscarinic Antagonists; Neoplasm Metastasis

2004
Sublingual hyoscyamine for patient comfort during screening sigmoidoscopy: a randomized, double-blind, placebo-controlled clinical trial.
    Gastrointestinal endoscopy, 1998, Volume: 48, Issue:3

    Topics: Adjuvants, Anesthesia; Administration, Sublingual; Adult; Aged; Aged, 80 and over; Atropine; Colorectal Neoplasms; Double-Blind Method; Female; Humans; Male; Mass Screening; Middle Aged; Patient Compliance; Patient Satisfaction; Premedication; Sigmoidoscopy

1998
Phase I dose-finding and pharmacokinetic trial of irinotecan hydrochloride (CPT-11) using a once-every-three-week dosing schedule for patients with advanced solid tumor malignancy.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:6

    Topics: Adjuvants, Anesthesia; Adult; Aged; Aged, 80 and over; Antidiarrheals; Antiemetics; Antineoplastic Agents, Phytogenic; Area Under Curve; Atropine; Camptothecin; Colorectal Neoplasms; Dexamethasone; Digestive System; Dose-Response Relationship, Drug; Esophageal Neoplasms; Female; Follow-Up Studies; Gallbladder Neoplasms; Glucuronates; Humans; Irinotecan; Loperamide; Male; Maximum Tolerated Dose; Middle Aged; Time Factors

2000

Other Studies

5 other study(ies) available for atropine and Colorectal Cancer

ArticleYear
Parasympathetic, but not sympathetic denervation, suppressed colorectal cancer progression.
    European journal of pharmacology, 2021, Dec-15, Volume: 913

    Topics: 1,2-Dimethylhydrazine; Animals; Atropine; Carcinogenesis; Carcinogens; Colon; Colorectal Neoplasms; Disease Progression; Ganglia, Sympathetic; Ganglionectomy; Guanethidine; Humans; Male; Mesentery; Neoplasms, Experimental; Parasympathetic Nervous System; Rats; Rats, Wistar; Vagotomy

2021
Blocking Muscarinic Receptor 3 Attenuates Tumor Growth and Decreases Immunosuppressive and Cholinergic Markers in an Orthotopic Mouse Model of Colorectal Cancer.
    International journal of molecular sciences, 2022, Dec-29, Volume: 24, Issue:1

    Topics: Animals; Atropine; B7-H1 Antigen; Cholinergic Agents; Colorectal Neoplasms; Lung Neoplasms; Mice; Proto-Oncogene Proteins c-akt; Receptor, Muscarinic M3; Receptors, Muscarinic

2022
Cholinergic signaling influences the expression of immune checkpoint inhibitors, PD-L1 and PD-L2, and tumor hallmarks in human colorectal cancer tissues and cell lines.
    BMC cancer, 2023, Oct-12, Volume: 23, Issue:1

    Topics: alpha7 Nicotinic Acetylcholine Receptor; Atropine; B7-H1 Antigen; Cholinergic Agents; Colorectal Neoplasms; ErbB Receptors; HT29 Cells; Humans; Immune Checkpoint Inhibitors; Programmed Cell Death 1 Ligand 2 Protein; Receptors, Muscarinic

2023
Irinotecan-related cholinergic syndrome induced by coadministration of oxaliplatin.
    Journal of the National Cancer Institute, 1998, Jan-21, Volume: 90, Issue:2

    Topics: Abdominal Pain; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Atropine; Blood Pressure; Camptothecin; Cholinergic Fibers; Colorectal Neoplasms; Female; Humans; Irinotecan; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Parasympatholytics; Salivation; Topoisomerase I Inhibitors

1998
Epidural anaesthesia and postoperative colorectal motility--a possible hazard to a colorectal anastomosis.
    International journal of colorectal disease, 1989, Volume: 4, Issue:3

    Topics: Aged; Anastomosis, Surgical; Anesthesia, Epidural; Atropine; Colorectal Neoplasms; Gastrointestinal Motility; Humans; Mepivacaine; Middle Aged; Neostigmine

1989